Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code C4A

Merkel cell carcinoma (MCC), a rare and aggressive skin cancer.

Use additional codes to document any associated functional activity (Chapter 4) or contributing factors.

Medical necessity is established by the diagnosis of Merkel cell carcinoma. Treatment is medically necessary to prevent further spread and improve patient outcomes.

Physicians diagnose MCC based on patient history, physical exam, and symptoms. Diagnostic procedures include biopsy, sentinel node biopsy, and imaging studies (CT, MRI, PET). Treatment depends on the stage and may involve surgery, radiation therapy, chemotherapy, and/or immunotherapy.

In simple words: Merkel cell carcinoma is a rare type of skin cancer that grows quickly. It often appears as a painless lump on the skin, which may be skin-colored or reddish-blue. It's more common in older people with fair skin and weakened immune systems. It's important to get any new or changing skin lumps checked by a doctor.

Merkel cell carcinoma (MCC), also known as neuroendocrine carcinoma of the skin or trabecular cancer, is a rare and aggressive malignancy arising from Merkel cells in the epidermis. It typically presents as a painless, rapidly growing nodule, often skin-colored, red, blue, or purplish-red, primarily on sun-exposed skin like the face, head, neck, arms, legs, and trunk. Individuals with fair skin, weakened immune systems, and those over 50 are at higher risk. MCC can metastasize quickly to regional lymph nodes and distant organs.

Example 1: A 70-year-old male with a history of sun exposure presents with a rapidly growing, painless, red nodule on his forehead. Biopsy confirms Merkel cell carcinoma., A 60-year-old female with a compromised immune system develops a flesh-colored lump on her arm.Following excision and sentinel node biopsy, she is diagnosed with Stage II Merkel cell carcinoma., A 55-year-old male with a history of MCC undergoes a PET scan which reveals metastases in the liver, indicating Stage IV disease. He receives chemotherapy and immunotherapy.

Documentation should include the location, size, and appearance of the lesion, biopsy results confirming MCC diagnosis, imaging reports, treatment plan, and follow-up notes regarding treatment response and any recurrence.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.